Professional Services

Clifford Chance advises UK government on £100m vaccine facility investment

The investment will fund a manufacturing site that will produce millions of doses of the vaccine each month

Clifford Chance has advised the UK government on its £100m investment to ensure that the Covid-19 vaccine can be manufactured at scale in Britain.

The magic circle law firm said on 27 July that the mandate was led by real estate partner Angela Kearns, life science partner Stephen Reese, and corporate partners Gareth Camp and Mark Poulton.

WSJ Logo